Physician profile
Howard T Tee
NPI 1972543486
$38,760.05
in general payments reported to CMS, 2019-2025
52 companies · $1,989 in 2025
The $1,989 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $1,731 · 2021: $4,931 · 2022: $3,397 · 2023: $5,488 · 2024: $3,768 · 2025: $1,989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,174 · Travel and Lodging: $1,903 · Education: $152 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,174.32 |
| Travel and Lodging | $1,903.26 |
| Education | $152.48 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14,007.12 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $2,594.79 | 2019-2025 | Wegovy, Ozempic |
| Boston Scientific Corporation | $2,116.06 | 2022-2025 | Watchman Access System, Watchman Flx |
| Cvrx, INC. | $2,100.75 | 2022-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $2,055.91 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,872.52 | 2019-2025 | Jardiance |
| Abbott Laboratories | $1,115.20 | 2019-2025 | Amplatzer Amulet, Mitraclip, Aveir |
| Pfizer INC. | $1,051.18 | 2019-2025 | |
| Amgen INC. | $1,042.97 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,028.26 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Merck Sharp & Dohme LLC | $946.21 | 2021-2025 | Verquvo, Capvaxive |
| Sanofi-Aventis U.S. LLC | $911.39 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $865.67 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $758.03 | 2019-2023 | Livalo |
| Biotronik INC. | $596.86 | 2019-2024 | Biomonitor, Edora 8 Dr-T, Amvia Edge |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $512.39 | 2019-2025 | Eliquis, Camzyos |
| Impulse Dynamics (USA) INC. | $508.39 | 2022-2025 | Optimizer, Optimizer |
| Esperion Therapeutics, INC. | $503.48 | 2020-2025 | Nexletol |
| Amarin Pharma, INC. | $360.29 | 2019-2022 | |
| Lundbeck LLC | $353.73 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $344.74 | 2019-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $339.88 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $329.27 | 2022-2023 | Opsumit |
| Edwards Lifesciences Corporation | $300.10 | 2019-2024 | Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $288.28 | 2021-2025 | Onpattro |
| Lexicon Pharmaceuticals, INC. | $178.14 | 2023-2024 | Inpefa |
| Lilly USA, LLC | $164.50 | 2021-2025 | Mounjaro |
| Silk Road Medical, INC. | $148.80 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Akcea Therapeutics, INC. | $146.53 | 2020 | |
| Medicure Pharma INC. | $139.36 | 2021-2023 | Zypitamag |
| Kestra Medical Technology Services, INC. | $128.80 | 2024-2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $115.63 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $88.88 | 2019-2021 | |
| Abiomed | $76.87 | 2022-2025 | |
| Resmed Corp | $75.79 | 2023 | |
| Amryt Pharma Holdings LTD | $65.09 | 2020 | |
| Medtronic, INC. | $60.82 | 2021-2023 | Reveal Linq, Azure Xt Dr Mri Surescan |
| Gilead Sciences, INC. | $58.40 | 2019 | |
| Bridgebio Pharma, INC. | $46.17 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, LTD. | $44.71 | 2022-2023 | Arcalyst |
| Coala Life INC | $43.31 | 2020 | |
| Glaxosmithkline, LLC. | $42.38 | 2025 | Shingrix, Arexvy |
| Aegerion Pharmaceuticals, INC. | $39.61 | 2019 | |
| Currax Pharmaceuticals LLC | $39.42 | 2021-2022 | |
| Scpharmaceuticals INC. | $27.35 | 2024 | |
| Astellas Pharma US INC | $23.45 | 2020 | |
| Bardy Diagnostics, INC. | $22.50 | 2020-2021 | |
| Atricure, INC. | $20.57 | 2024 | |
| Altathera Pharmaceuticals LLC | $16.86 | 2024 | Sotalol Hydrochloride |
| Baxter Healthcare | $15.00 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Vital Connect, INC | $14.22 | 2025 | Vitalpatch Rtm |
| Sobi, INC | $13.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Tee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.